Is hospitalization after TIA cost-effective on the basis of treatment with tPA?

被引：75

作者：

Nguyen-Huynh, MN

Johnston, SC

机构：

[1] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA

来源：

NEUROLOGY | 2005年 / 65卷 / 11期

关键词：

D O I：

10.1212/01.wnl.0000187067.93321.fa

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A 24-hour hospitalization for TIA could be cost-effective simply by increasing the likelihood that patients will receive tissue plasminogen activator if a stroke occurs. The authors performed a cost-utility analysis of 24-hour hospitalization for patients diagnosed with recent TIA. The overall cost-effectiveness ratio was $55,044 per quality-adjusted life-year, a value considered borderline cost-effective. For patients with higher risk of stroke, admission was cost-effective.

引用

页码：1799 / 1801

页数：3

共 9 条

[1] Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke [J].

Fagan, SC ;

Morgenstern, LB ;

Petitta, A ;

Ward, RE ;

Tilley, BC ;

Marler, JR ;

Levine, SR ;

Broderick, JP ;

Kwiatkowski, TG ;

Frankel, M ;

Brott, TG ;

Walker, MD .

NEUROLOGY, 1998, 50 (04) :883-890

[2]

GGOLD MR, 1996, COST EFFECTIVENESS H

[3] Management and outcomes of transient ischemic attacks in Ontario [J].

Gladstone, DJ ;

Kapral, MK ;

Fang, JM ;

Laupacis, A ;

Tu, JV .

CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 170 (07) :1099-1104

[4]

Hills NK, 2004, ANN NEUROL, V56, pS3

[5] Utilization of intravenous tissue-type plasminogen activator for ischemic stroke at academic medical centers - The influence of ethnicity [J].

Johnston, SC ;

Fung, LH ;

Gillum, LA ;

Smith, WS ;

Brass, LM ;

Lichtman, JH ;

Brown, AN .

STROKE, 2001, 32 (05) :1061-1067

[6] Short-term prognosis after emergency department diagnosis of TIA [J].

Johnston, SC ;

Gress, DR ;

Browner, WS ;

Sidney, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (22) :2901-2906

[7] Very early risk of stroke after a first transient ischemic attack [J].

Lovett, JK ;

Dennis, MS ;

Sandercock, PAG ;

Bamford, J ;

Warlow, CP ;

Rothwell, PM .

STROKE, 2003, 34 (08) :E138-E140

[8] TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE ISCHEMIC STROKE [J].

MARLER, JR ;

BROTT, T ;

BRODERICK, J ;

KOTHARI, R ;

ODONOGHUE, M ;

BARSAN, W ;

TOMSICK, T ;

SPILKER, J ;

MILLER, R ;

SAUERBECK, L ;

JARRELL, J ;

KELLY, J ;

PERKINS, T ;

MCDONALD, T ;

RORICK, M ;

HICKEY, C ;

ARMITAGE, J ;

PERRY, C ;

THALINGER, K ;

RHUDE, R ;

SCHILL, J ;

BECKER, PS ;

HEATH, RS ;

ADAMS, D ;

REED, R ;

KLEI, M ;

HUGHES, S ;

ANTHONY, J ;

BAUDENDISTEL, D ;

ZADICOFF, C ;

RYMER, M ;

BETTINGER, I ;

LAUBINGER, P ;

SCHMERLER, M ;

MEIROSE, G ;

LYDEN, P ;

RAPP, K ;

BABCOCK, T ;

DAUM, P ;

PERSONA, D ;

BRODY, M ;

JACKSON, C ;

LEWIS, S ;

LISS, J ;

MAHDAVI, Z ;

ROTHROCK, J ;

TOM, T ;

ZWEIFLER, R ;

DUNFORD, J ;

ZIVIN, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1581-1587

[9] In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up [J].

Ovbiagele, B ;

Saver, JL ;

Fredieu, A ;

Suzuki, S ;

Selco, S ;

Rajajee, V ;

McNair, N ;

Razinia, T ;

Kidwell, CS .

STROKE, 2004, 35 (12) :2879-2883

← 1 →